Skip to main content

Table 1 Patient characteristics

From: 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study

Parameter

Median (range)

n = 30

%

Age (years)

57.4 (36.9–78.9)

 

Gender

 male

 

22

73

 emale

8

27

Body Mass Index (kg/m2)

23.2 (16.7–30.8)

 

Charlson-comorbidity-Index

 2

 

23

77

 3–5

4

13

  > 6

3

10

ECOG score

 0

 

22

73

 1

8

27

Localization

 AEG Siewert Type II

 

12

40

 AEG Siewert Type III

10

34

 Gastric cancer

8

26

Grading

 G2

 

14

47

 G3

16

53

Laurén’s classification

 Intestinal

 

24

80

 Mixed

3

10

 Diffuse

3

10

uT-category

 uT2

 

4

13

 uT3

22

74

 uT4

4

13

cN-category

 cN0

 

3

10

 cN+

27

90

cM-category

 cM0

 

24

80

 cM1

6

20

  1. Clinical TNM staging is based on EUS (uT) and/or CT or PET-CT (cN)